Sponsored Content

Double algae power for better health

Vitafoods Europe, stand H110: AstaReal presents new formulation that combines different microalgae-derived ingredients

Nacka (Sweden), March 2024 – AstaReal, global pioneer in production of natural algal astaxanthin, presents its new finished formulation at this year’s Vitafoods. For optimal health support, the new product combines two algal-derived ingredients, astaxanthin and omega-3 fatty acids. It was developed in cooperation with the French omega-3 expert Polaris. AstaReal will also showcase its classic retail supplement Astaxin®, which was recently rebranded with a more modern new look.

AstaReal has added a new finished formula to its range of natural astaxanthin products and will showcase it at Vitafoods for the first time. For the microalgae combination, AstaReal partnered with the French company Polaris to create a sustainable and vegan product that contains not only astaxanthin but also omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). While astaxanthin from microalgae Haematococcus pluvialis is a strong antioxidant with cell protective power, EPA and DHA from microalgae Schizochytrium are important for flexible membranes and contribute to the normal function of the heart. DHA also contributes to the maintenance of normal brain function and vision.

Alongside its new microalgae combination, which will be presented at the new product zone, AstaReal will showcase its proven range of high-quality astaxanthin bulk products and finished formulations. Visitors can also take a look at the recently rebranded Astaxin®: AstaReal’s well established retail product now has a minimalist Nordic look. It contains astaxanthin, vitamin C and E – the two latter contribute to the protection of cells from oxidative stress. Besides human grade formulations, AstaReal also offers astaxanthin for animals through its feed and pet food grade NOVASTA®, with products such as EB15 known for high stability.

Peter Ahlm, Head of Marketing & Sales at AstaReal, comments: “We are excited to introduce our new finished formulation that combines the most precious ingredients found in microalgae, namely astaxanthin and long-chained omega-3 fatty acids. Through this launch, we are committing to algae as a plant-based, fast-regrowing and future-proof source which will gain further traction in the nutrition and supplement market. One pillar in the success of algae is the growing scientific research on its ingredients. With our longstanding expertise as well as through our studies and clinical trials, we contribute to a better understanding of astaxanthin and its health benefits for humans and animals.”

About AstaReal AB

AstaReal AB is part of the AstaReal Group, which is a wholly owned subsidiary of the Japanese pharmaceutical company Fuji Chemical Industries Co. Ltd. The Group uses AstaReal® as the global brand name for its natural algal astaxanthin products. As a worldwide pioneer and expert in natural astaxanthin production, R&D and clinical studies, the company offers a variety of specialized astaxanthin formats to help meet customer requirements when developing dietary supplements, sports nutrition products, cosmetics and animal feed.

AstaReal AB is ISO 9001, FSSC 22000, Informed Ingredient, Kosher, and Halal certified, and carries the Vegan Trademark for its bulk products. The company’s roots trace back to the prestigious Uppsala University, Sweden.

Successfully proven benefits of natural astaxanthin for human health encouraged the scientists there to establish AstaReal’s first production facility in Gustavsberg, Sweden, in the early 1990s. In 1995, AstaReal AB launched Astaxin® – the first human nutritional supplement containing a natural source of astaxanthin. Today, AstaReal produces natural astaxanthin at facilities in Sweden and the USA. AstaReal AB offers private labelling, and is open to co-branding and joint product development.

For further information, please visit: https://www.astareal.se

Read More